证券代码：000638 证券简称：*ST 万方 万方城镇投资发展股份有限公司投资者关系活动记录表 | 投资者关系活动 | □特定对象调研□分析师会议 | | --- | --- | | 类别 | □媒体采访√业绩说明会 | | | □新闻发布会□路演活动 | | | □现场参观 | | | □其他（请文字说明其他活动内容） | | 参与单位名称及 | 投资者网上提问 | | 人员姓名 | | | 时间 | 2025 年 5 月 27 日 (周二) 下午 15:00~16:30 | | 地点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | 采用网络远程的方式召开业绩说明会 | | 上市公司接待人 | 1、董事长、总经理刘玉女士 | | 员姓名 | 2、副董事长、副总经理、董事会秘书郭子斌女士 | | | 3、副总经理董威亚先生 | | | 4、财务总监谌志旺先生 | | | 投资者提出的问题及公司回复情况 | | | 公司就投资者在本次说明会中提出的问题进行了回复： | | | 1、请问公司目前虾青素基地一期工程修好了没？ | | | 您好,感谢您的提问,目前公司的 ...

New Stock Issuance - New stock issuance for Jiao Da Tie Fa at an issuance price of 8.81[1] - ST Li Fang and United Chemical have recent announcements dated May 14 and May 23 respectively[1] - Multiple companies including Zhongzhou Special Materials and San Sheng Guo Jian have announcements on May 23[1] Market Alerts - Significant abnormal fluctuations reported for Nanjing Port and Li Jun Co. on May 23[1] - ST Er Ya and ST Jin Hong have recent announcements regarding market conditions[1] - Companies like Hainan Development and ST Haihua have reported abnormal trading activities[1] Trading Updates - Trading updates for various companies including ST Ya Zhen and ST Jian Gang on May 27[1] - Multiple companies have links to their announcements for further details on trading activities[1] - The report includes a comprehensive list of companies with their respective announcement dates and links for investor reference[1]

Group 1 - The recombinant protein concept sector rose by 2.52%, ranking second among concept sectors, with 30 stocks increasing in value [1][2] - Notable gainers included Sangon Biotech, which hit the daily limit with a 20% increase, and other significant performers such as Sai Sheng Pharmaceutical, Jie Ya Co., and Jinbo Bio, which rose by 16.37%, 9.31%, and 9.17% respectively [1][2] - The sector experienced a net inflow of 221 million yuan from main funds, with 23 stocks receiving net inflows, and 8 stocks exceeding 10 million yuan in net inflow [2][3] Group 2 - Leading the net inflow was Xilong Scientific, which saw a net inflow of 242 million yuan, followed by Rejuve Pharmaceutical and Zexin Pharmaceutical with net inflows of 37.78 million yuan and 32.48 million yuan respectively [2][3] - The top three stocks by net inflow ratio were Xilong Scientific at 20.85%, Zexin Pharmaceutical at 8.53%, and Chengdu Xian Dao at 7.96% [3][4] - Stocks with notable declines included Furuida, Zhongyuan Xiehe, and Wanmei Biological, which fell by 2.25%, 1.92%, and 1.80% respectively [1][5]

万方城镇投资发展股份有限公司 2024年年度股东大会决议公告 本公司及其董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会没有出现否决提案的情形。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 1、股东大会届次：2024年年度股东大会。 2、召集人：万方城镇投资发展股份有限公司第十届董事会。 证券代码：000638 证券简称：*ST 万方 公告编号：2025-035 4、会议召开的合法、合规性：公司第十届董事会第二次会议审议通过了《关 于召开2024年年度股东大会的议案》，本次股东大会的召集、召开程序符合法律 法规、深圳证券交易所业务规则和公司章程的相关规定。 股东出席的总体情况： | 会议出席情况 | 出席会议 | | 其中 | | | | --- | --- | --- | --- | --- | --- | | | 的股东及 | | | | | | | 股东授权 | 出席现场会议的股东 | | 以网络投票方式参加会议 | | | | 委托代表 | 及股东授权委托代表 | | 的股东 | | | 股东出席的 ...

证券代码：000638 证券简称：*ST 万方 公告编号：2025-036 万方城镇投资发展股份有限公司 关于参加网上集体业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net）；或关注微信公众号（名称：全景财经）；或下载全景路演 APP, 参与本次互动交流。活动时间为 2025 年 5 月 27 日（星期二）15:00-16:30。 届时公司董事长兼总经理刘玉女士，副董事长兼副总经理兼董事会秘书郭子 斌女士，副总经理董威亚先生，财务总监谌志旺先生将在线就公司 2024 年度业 绩、公司治理、发展战略、经营状况等投资者关心的问题，与投资者进行沟通与 交流，欢迎广大投资者踊跃参与！ 特此公告。 万方城镇投资发展股份有限公司 董 事 会 二〇二五年五月二十日 1 / 1 为进一步加强与投资者的互动交流，万方城镇投资发展股份有限公司（以下 简称"公司"）将参加由吉林省证券业协会、深圳市全景网络有限公司共同举办 的"2025 年吉林辖区上市公司投资者网上集体 ...

万方发展 2024年年度股东大会法律意见书 北京国南律师事务所 北京国南律师事务所 关于万方城镇投资发展股份有限公司 2024年年度股东大会的法律意见书 致：万方城镇投资发展股份有限公司 北京国南律师事务所（以下简称"本所"）接受万方城镇投资发展股份有限公司 （以下简称"公司"）委托，指派马磊、陈磊磊律师（以下合称"本所律师"）列席并见 证公司2024年年度股东大会（以下简称"本次股东大会"）。 1、本次股东大会的召集人为公司第十届董事会。 万方发展 2024年年度股东大会法律意见书 北京国南律师事务所 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公司股东大 会规则》等法律、行政法规及《万方城镇投资发展股份有限公司章程》（以下简称 "《公司章程》"）的有关规定，按照律师行业公认的业务标准、道德规范和勤勉尽责 精神，本所律师对本次股东大会的有关事项进行了核查和验证，出具法律意见书。 本所对本法律意见书的出具特做如下声明： 对于出席现场会议的公司股东和股东授权代理人在办理出席会议登记手续时向公 司出示的身份证件、营业执照、授权委托书、股票账户卡等材料，其真实性、有效性 应当由出席股东和股东授权代 ...

证券代码：000638 证券简称：*ST 万方 公告编号：2025-034 万方城镇投资发展股份有限公司 关于股票交易异常波动的公告 本公司及其董事会全体成员保证信息披露内容的真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 特别提示： 1、万方城镇投资发展股份有限公司（以下简称"公司"）（证券代码：000638， 证券简称：*ST 万方）股票连续三个交易日（2025 年 5 月 13 日至 2025 年 5 月 15 日）收盘价格涨幅累计偏离值累计为 16.99％，根据《深圳证券交易所交易规则》 （2023 年修订）的相关规定，属于股票交易异常波动。 2、经向公司控股股东、实际控制人发函核实：截至本公告披露日，不存在应 披露而未披露的信息。 3、公司于 2025 年 4 月 29 日披露了《2024 年年度报告》《关于公司股票交 易被实施退市风险警示暨停牌的公告》， 2024 年度经审计扣除非经常性损益后 的净利润为负值，且扣除后的营业收入低于 3 亿元。根据《深圳证券交易所股票 上市规则》（2024 年修订）第 9.34 条的规定，自 2025 年 4 月 30 日公司股票交 易被实施退市风险警示 ...

Group 1 - The grain concept sector rose by 1.13%, ranking 10th among concept sectors, with 27 stocks increasing in value [1] - Notable gainers included Chuaning Biological, which hit a 20% limit up, and *ST Wanfang, which also reached the limit up, while Qiu Le Seed Industry and Shennong Seed Industry rose by 6.81% and 3.50% respectively [1] - The sector saw a net inflow of 433 million yuan from main funds, with 22 stocks receiving net inflows, and 8 stocks exceeding 10 million yuan in net inflow [2] Group 2 - Chuaning Biological led the net inflow with 558 million yuan, followed by Shennong Seed Industry and Weiwei Shares with net inflows of 56.82 million yuan and 29.74 million yuan respectively [2][3] - The net inflow ratio for *ST Wanfang was 92.90%, indicating a strong interest from main funds [3] - Other stocks with significant net inflow ratios included Chuaning Biological at 28.09% and Huazi Industry at 12.25% [3] Group 3 - The top gainers in the grain concept sector included Chuaning Biological, which had a trading volume turnover rate of 23.97%, and Shennong Seed Industry with a turnover rate of 24.42% [3] - Stocks such as Weiwei Shares and Black Sesame also showed positive performance with increases of 2.26% and 1.87% respectively [3] - Conversely, stocks like Tianhong Shares and Lianhua Holdings experienced declines of 3.89% and 2.91% respectively, indicating a mixed performance within the sector [5]

1.主营业务不突出，多元化转型失败： 万方发展在转型过程中涉足了多个领域，但并未形成具有核心竞争力的主营业务。多元化转型并未带来预期的业绩增长，反而分散了公司的资源和精力，导 致整体业绩下滑。 万方发展（股票代码：000638）是一家在我国深圳证券交易所主板上市的公司，其主营业务涵盖了房地产、军工、农业产业以及医疗信息化软件开发和销售 等多个领域。公司曾通过资产并购等方式谋求转型，先后涉足互联网医疗、金融、VR硬件、大数据分析及军工等领域。然而，近年来万方发展的经营状况 却每况愈下，成为了一个典型的上市公司经营失败案例。 万方发展的成功史可以追溯到其早期以地产为主营业务的时期。1996年，万方发展登陆A股市场，凭借在房地产领域的深耕细作，公司一度取得了不俗的业 绩。然而，随着市场竞争的加剧和宏观调控政策的影响，万方发展的地产业务逐渐陷入困境。为了寻求新的增长点，公司开始通过资产并购等方式谋求转 型。 在转型过程中，万方发展先后涉足了互联网医疗、金融、VR硬件、大数据分析及军工等多个领域。其中，互联网医疗和军工板块曾一度成为公司的亮点。 例如，公司与四川省卫计委签订《战略合作框架协议》，共同打造智慧化医疗服务生 ...

Group 1 - Major shareholders of *ST WanFang plan to reduce their holdings by up to 9,341,596 shares, accounting for 3% of the company's total share capital from May 27 to August 25, 2025 [1] - Shareholders of Airo Energy intend to reduce their holdings by up to 800,000 shares, 800,000 shares, and 1,600,000 shares, representing 0.50%, 0.50%, and 1% of the company's total share capital respectively during the same period [1] - Anner plans to reduce its holdings by up to 3,186,159 shares, which is 1.5% of the company's total share capital, from May 27 to August 26, 2025 [1] Group 2 - Shareholders of Chuhuan Technology plan to reduce their holdings by up to 2,395,605 shares, accounting for 3% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [1] - Major shareholder of Dalian Technology intends to reduce their holdings by up to 4,189,336 shares, which is 0.99% of the company's total share capital from May 27 to August 26, 2025 [2] - Dongwei Technology's board members plan to reduce their holdings by a total of 2,574,857 shares, representing 0.8629% of the company's total share capital during the same period [2] Group 3 - Gann Li Pharmaceutical's shareholder has completed a reduction of 6,010,622 shares, which is 1% of the company's total share capital from April 22 to April 30, 2025 [2] - Guanshi Technology's board members plan to reduce their holdings by up to 359,375 shares, accounting for 0.4891% of the company's total share capital from May 27 to August 26, 2025 [2] - Guoguang Electric's shareholder has completed a reduction of 1,625,751 shares, which is 1.5% of the company's total share capital from April 25 to April 30, 2025 [2] Group 4 - Haili Biological's major shareholder has completed a reduction of 13,113,244 shares, representing 2% of the company's total share capital from April 15 to April 22, 2025 [3] - Hengfeng Information's board member has completed a reduction of 198,717 shares, which is 0.1207% of the company's total share capital on April 28, 2025 [3] - Hongwei Technology's shareholder plans to reduce their holdings by up to 820,000 shares, accounting for 0.39% of the company's total share capital from May 12 to August 11, 2025 [3] Group 5 - Huatai Medical's vice president has completed a reduction of 29,943 shares, which is 0.0308% of the company's total share capital from April 28 to April 29, 2025 [4] - Jilin Carbon Valley's major shareholder has completed a reduction of 4,989,160 shares, representing 0.8490% of the company's total share capital from April 25 to April 29, 2025 [4] - Jiahua Technology's shareholder plans to reduce their holdings by up to 1,160,000 shares, accounting for 1.50% of the company's total share capital from May 28 to August 25, 2025 [4] Group 6 - Jiangbo Long's shareholder plans to reduce their holdings by up to 4,159,815 shares, which is 1% of the company's total share capital from May 27 to August 26, 2025 [5] - Jiangshan Co. plans to reduce its holdings in Jiangtian Chemical by 4,330,800 shares, accounting for 3% of its total share capital from May 27 to August 26, 2025 [5] - Kairun Co.'s major shareholder plans to reduce their holdings by up to 9,000,000 shares, representing 2.43% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [5] Group 7 - Lianqi Technology's shareholders plan to reduce their holdings by a total of 18,717,374 shares, which is 2.96% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [9] - Zhongke Information's board members have completed a reduction of 698,914 shares, representing 0.2358% of the company's total share capital [9] - Zhongshi Co.'s major shareholder plans to reduce their holdings by up to 1,800,000 shares, accounting for 1.1527% of the company's total share capital from May 27 to August 26, 2025 [10]